These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 24419919)
41. [Alpha-adrenergic blockers as a support in the treatment of acute urinary retention]. Altarac S Lijec Vjesn; 2006; 128(7-8):233-7. PubMed ID: 17087140 [TBL] [Abstract][Full Text] [Related]
42. Urinary retention in women. Juma S Curr Opin Urol; 2014 Jul; 24(4):375-9. PubMed ID: 24901515 [TBL] [Abstract][Full Text] [Related]
43. An algorithm for medical management in male lower urinary tract symptoms. Djavan B; Margreiter M; Dianat SS Curr Opin Urol; 2011 Jan; 21(1):5-12. PubMed ID: 21045704 [TBL] [Abstract][Full Text] [Related]
44. Lower urinary tract symptoms in the older male. Hsieh K; Taylor JA; Albertsen PC Conn Med; 2003 Sep; 67(8):487-90. PubMed ID: 14587129 [TBL] [Abstract][Full Text] [Related]
45. Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study. McNeill SA; Hargreave TB; Roehrborn CG; Urology; 2005 Jan; 65(1):83-9; discussion 89-90. PubMed ID: 15667868 [TBL] [Abstract][Full Text] [Related]
46. [Lower urinary tract symptoms and pelvic floor dysfunction in renal transplant candidates and recipients]. Thuret R; Hurel S; Kleinclauss F; Timsit MO Prog Urol; 2016 Nov; 26(15):1114-1121. PubMed ID: 27727093 [TBL] [Abstract][Full Text] [Related]
50. Transurethral vaporization of the prostate in the treatment of bladder outlet obstruction at two university hospitals. Gerber GS; Jahoda A; Bales GT; Albala DM Tech Urol; 1997; 3(1):25-9. PubMed ID: 9170221 [TBL] [Abstract][Full Text] [Related]
51. BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE. Roehrborn CG BJU Int; 2008 Mar; 101 Suppl 3():17-21. PubMed ID: 18307681 [TBL] [Abstract][Full Text] [Related]
52. Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia. Carnevale FC; da Motta-Leal-Filho JM; Antunes AA; Baroni RH; Marcelino AS; Cerri LM; Yoshinaga EM; Cerri GG; Srougi M J Vasc Interv Radiol; 2013 Apr; 24(4):535-42. PubMed ID: 23434084 [TBL] [Abstract][Full Text] [Related]
53. Intermittent catheterization time required after interstitial laser coagulation of the prostate. Nishizawa K; Kobayashi T; Mitsumori K; Watanabe J; Ogura K Urology; 2004 Jul; 64(1):79-83. PubMed ID: 15245940 [TBL] [Abstract][Full Text] [Related]
54. Feedback microwave thermotherapy with the ProstaLund Compact Device for obstructive benign prostatic hyperplasia: 12-month response rates and complications. Alivizatos G; Ferakis N; Mitropoulos D; Skolarikos A; Livadas K; Kastriotis I J Endourol; 2005; 19(1):72-8. PubMed ID: 15735388 [TBL] [Abstract][Full Text] [Related]
56. Spectrum of urodynamic abnormalities and renal function changes in adult men with non-neurogenic urinary retention. Lewis JM; Yalla SV; Stanitski KE; Sullivan MP Neurourol Urodyn; 2012 Apr; 31(4):544-8. PubMed ID: 22298049 [TBL] [Abstract][Full Text] [Related]
57. The role of alpha1-adrenergic receptor subtypes in lower urinary tract symptoms. Schwinn DA BJU Int; 2001 Sep; 88 Suppl 2():27-34; discussion 49-50. PubMed ID: 11589667 [No Abstract] [Full Text] [Related]